{
    "pmcid": "11066466",
    "qa_pairs": {
        "What are the three categories of EMA methods discussed in the paper?": [
            "Consensus, quasi-single model, and single model methods",
            "Consensus, dual model, and hybrid model methods",
            "Single model, multi-model, and hybrid model methods",
            "Quasi-single model, dual model, and consensus methods"
        ],
        "What challenge does the paper emphasize in the context of SARS-CoV-2 nanobody binders?": [
            "The variability and flexibility of antibody-antigen interactions",
            "The lack of available structural data for SARS-CoV-2 proteins",
            "The high mutation rate of the SARS-CoV-2 virus",
            "The difficulty in synthesizing nanobodies in the laboratory"
        ],
        "What is the significance of Interface Residue-Wise Score (IRWS) as discussed in the paper?": [
            "It is critical for assessing the stability and function of protein complexes",
            "It helps in determining the overall folding pattern of proteins",
            "It is used to predict the solubility of protein complexes",
            "It measures the binding affinity of small molecules to proteins"
        ],
        "What potential does ESM have in the context of antibody modeling according to the paper?": [
            "Improving the evaluation of immunity complexes by leveraging pre-trained models on natural antibody sequences",
            "Enhancing the synthesis of antibodies in laboratory settings",
            "Increasing the speed of protein structure prediction",
            "Reducing the computational cost of protein modeling"
        ],
        "Which method is mentioned as using embeddings from protein language models like ESM to enhance prediction of complex structures?": [
            "GraphCPLMQA",
            "DeepUMQA3",
            "AlphaFold2",
            "Quasi-Single Model Method"
        ]
    }
}